Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric Glaucoma
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
Objectives:
The study will assess the ocular hypotensive effect of latanoprost and dorzolamide in a
selected sample of patients affected by primary Pediatric Glaucoma (PG), refractory to
surgical procedures. Safety will be assessed, too.In the first version of the protocol 96
eyes were forecasted to complete the enrolment. The protocol was then amended and now to
complete the study 68 eyes should be included. This number of eyes could be achieved by
recruiting from 34 to 68 patients due to not in all patients both eyes should be eligible for
the study.
Phase:
Phase 2
Details
Lead Sponsor:
Azienda Ospedaliera Spedali Civili di Brescia Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia